Advertisement
Organisation › Details
OxStem Ltd.
OxStem was founded in 2014 by Professor Steve Davies, Professor Dame Kay Davies, Professor Angela Russell and a number of Oxford--based angel investors. OxStem is positioned to transform the field of medical therapeutics for what are typically (but certainly not exclusively) age--related conditions, such as Dementia, Heart Failure, Macular Degeneration (the leading cause of blindness in the developed world), Diabetes and Oncology. OxStem is comprised of an internationally respected top tier scientific team with a strong track record in both translational bioscience and commercialising world--class scientific innovation. The idea is straightforward: to use the Stem Cell and Medicinal Chemistry expertise within Chemistry and its associated partners at Oxford to identify new classes of drugs that can re- program or stimulate existing endogenous cells – awakening previously defunct or dormant cellular processes. At present, most cell therapies are based on in vitro manipulation of the cells and transplantation into the patient. The OxStem hypothesis is that since the body has existing in situ adult stem and precursor cells, using high throughput phenotypic screens (based on cultures of tissue specific cells and targeted compound libraries), we can identify new classes of compounds that are able to stimulate these cells in situ. *
Start | 2014-01-01 splitoff | |
Group | OxStem (Group) | |
Predecessor | University of Oxford, Chemistry Department | |
Industry | small-molecule drug | |
Industry 2 | stem cell technology | |
Person | Stein, Michael (OxStem 201605 CEO) | |
Person 2 | Davies, Steve (Univ Oxford 201605 Professor at Dept of Chemistry) | |
Region | Oxford, Oxfordshire | |
Country | United Kingdom (GB) | |
Street | 12 Mansfield Road c/o Prof. Steve Davies, Chemistry Research Labs | |
City | OX1 3TA Oxford, Oxfordshire | |
Tel | +44-1865-275-646 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2023-07-10 |
Advertisement
More documents for OxStem (Group)
- [1] Coulter Partners. (1/22/20). "Press Release: Coulter Partners Secures Chief Scientific Officer for OxStem"....
- [2] CytoSeek Ltd.. (1/20/20). "Press Release: CytoSeek Appoints a CEO". Bristol....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top